M Holdings Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,567
Closed -$849K 166
2024
Q2
$849K Buy
+1,567
New +$828K 0.11% 110
2023
Q3
Sell
-825
Closed -$367K 229
2023
Q2
$367K Sell
825
-2,341
-74% -$1.08M 0.08% 133
2023
Q1
$1.46M Sell
3,166
-785
-20% -$374K 0.15% 111
2022
Q4
$2.03M Sell
3,951
-40
-1% -$20.3K 0.21% 92
2022
Q3
$1.81M Buy
3,991
+42
+1% +$20.1K 0.2% 94
2022
Q2
$1.91M Sell
3,949
-22
-0.6% -$10.9K 0.19% 93
2022
Q1
$1.95M Buy
+3,971
New +$1.82M 0.15% 108
2021
Q2
Sell
-3,721
Closed -$1.34M 310
2021
Q1
$1.34M Buy
+3,721
New +$1.2M 0.12% 154
2014
Q4
Sell
-16,500
Closed -$12K 245
2014
Q3
$12K Buy
+16,500
New +$1.89M 0.01% 527

Other funds holding ELV

M Holdings Securities's ELV Position: Q3 2024 in Review

M Holdings Securities sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 1,567 shares — an estimated $849K sold.

M Holdings Securities first reported a position in ELV in Q3 2014 and held it in 9 quarters. The position peaked at $2.03M in Q4 2022. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • M Holdings Securities reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • M Holdings Securities sold 1,567 Elevance Health shares in Q3 2024, an estimated $849K.
  • M Holdings Securities first reported a position in Elevance Health in Q3 2014 and held it in 9 quarters.
  • M Holdings Securities's Elevance Health position peaked at $2.03M in Q4 2022.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on M Holdings Securities's 13F filing for Q3 2024, filed 12 Nov 2024.